SANTA BARBARA, CA -- (Marketwire) -- 11/18/09 -- Wiley Systems(TM), Inc., developer of the Wiley Protocol biomimetic rhythmic hormones, announced today that its founder, author and researcher T.S. Wiley, who wrote "Sex, Lies, and Menopause" (Harper Collins), warned women six years ago about the dangers of mammography, devoting an entire chapter to mammograms, breast cancer, and other misconceptions. The U.S. Preventive Services Task Force (USPSTF) of the Department of Health and Human Services has reversed existing recommendations that women get mammograms every one or two years starting at 40, now recommending biennial screening mammography for women aged 50 to 74 years. The guidelines also downplay the effectiveness of self-examinations.

Quoting from the book, Chapter 5, p. 97, Wiley stated, "Using X-rays to see abnormalities in breast tissue had been around since 1913, but had never really become a diagnostic tool until the mid-1970s. When a pinpoint lesion appears in your breast, there may already be cancer cells multiplying in the shin of your leg, in your bone marrow. The pin-point size lesion that a mammogram picks up is only a symptom of what's happening elsewhere in your body."

The U.S. Preventive Services Task Force, a government panel of doctors and scientists, concluded that such early and frequent screenings often lead to false alarms and unneeded biopsies without substantially improving women's odds of survival. The task force concluded one cancer death is prevented for every 1,904 women age 40 to 49 who are screened for 10 years, compared with one death for every 377 women age 60 to 69.

Wiley continues, "The other problem with mammography is obvious: Science only knows of one absolute carcinogen to human tissue on the planet, and that carcinogen is ionizing radiation. If the exposed cells don't die, the DNA breaks and they mutate. Cancer rarely starts with a mutated gene; but a gene certainly can be mutated by an outside-the-body influence like the ionizing radiation of power lines or mammography. Mammography is ionizing radiation."

The USPSTIF Summary of Recommendations recommends biennial screening mammography for women aged 50 to 74 years, concludes that the current evidence is insufficient to assess the additional benefits and harms of screening mammography in women 75 years or older, recommends against teaching breast self-examination (BSE), concludes that the current evidence is insufficient to assess the additional benefits and harms of clinical breast examination (CBE) beyond screening mammography in women 40 years or older, and concludes that the current evidence is insufficient to assess the additional benefits and harms of either digital mammography or magnetic resonance imaging (MRI) instead of film mammography as screening modalities for breast cancer.

"Sex, Lies, and Menopause" also mentions historical research on the topic: "In 1975 the Breast Cancer Detection Demonstration Project (BCDDP), which was to enroll 270,000 women age thirty-four to seventy-five, had just begun. Their doctors, who were recruited by the BCDDP to be partners in the study, offered free mammograms to women. Twenty years earlier, in 1955, during the first big push for mammography, a Dr. McKinnon had commented earlier detection and treatment are meaningless. In the face of the fact that 50 percent of all slow-growing lesions have little if any tendency to give rise to metastases, 'curing non-lethal lesions does nothing to reduce mortality.' By October 1, 1975, excerpts from an unpublished medical article alleging that mammograms done by BCDDP might be causing more breast cancer than they were helping to cure was published by Washington Post columnist Jack Anderson. Anderson received the tip about the article from the National Cancer Institute's Deputy Associate Director for Cancer Control, John Bailar. With respect to the hazards of mammography, Bailar himself published an article in the Annals of Internal Medicine pointing out there was experimental and clinical evidence that ionizing radiation can cause breast cancer."

The more radiation a woman receives in her lifetime, whether it's during a dental exam, at the airport, or during her yearly mammography, the more likely it is that she will have breast cancer ten to fifteen years later.

Finally, the author notes, "You just don't irradiate the one part of your body that you don't want to get cancer with the one thing that everybody agrees causes cancer."

T.S. Wiley is the developer of The Wiley Protocol® rhythmic, compounded bioidentical hormones, and has pioneered the standardization of the patent pending Wiley Protocol formulations using unique, standardized compounding procedures and color coded packaging, available to physicians and patients at recommended retail prices. The company's biomimetic hormone protocols must be formulated by a trained and registered compounding pharmacist.

To learn more online, visit www.thewileyprotocol.com or go to the Bioidenticals Channel on YouTube where you may watch and listen to patients and doctors talk about their experiences with the rhythmic Wiley Protocol.

T.S. Wiley is a medical theorist in environmental endocrinology and Darwinian medicine. She is a noted writer, researcher and lecturer on the effects of hormones, particularly in menopausal women as well as an accepted expert in chronobiology and circadian rhythmicity. Wiley's environmental endocrinology seminars, "Two Days Back on Earth" in Glendale, California are attended by physicians from around the world.

About Wiley Systems, Inc. and the Wiley Protocol

Wiley Systems, Inc. was founded in 2005 in Santa Barbara, California by T.S. Wiley, who is the developer of the Wiley Protocol®, a trademarked patent pending delivery system consisting of the biomimetic, bioidentical hormones estradiol and progesterone, or biomimetic hormone restoration therapy. Wiley Systems began as a project to fund the union of doctors and pharmacists in a common goal to standardize bioidentical hormones for academic research. Now in 2009, the Wiley Pharmacy Consortium numbers around 50 pharmacies and more than 250 doctors prescribing in the US and Canada.

The Wiley Protocol is only available at compounding pharmacies that have joined the project for future National Institutes of Health (NIH) study and have contractually agreed to the standardized methods, materials, packaging and recommended pricing. In exchange, Wiley Systems provides intellectual property and provides 28WP logo-bearing packaging consisting of color-coded bags and applicators. The Wiley Protocol name assures customers that they are receiving authentic Wiley Protocol dosing rhythms based on original research.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=1119243

Add to Digg Bookmark with del.icio.us Add to Newsvine